During the past decade, LTD Cancer Research Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LTD Cancer Research Centre" are "Breast Cancer" (1 trials), "Head and Neck Cancer" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Relapsed Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "LTD Cancer Research Centre" in a lesser frequency.

Most popular intervention types in "LTD Cancer Research Centre" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "EG12014" (1 trials), "EU-approved Avastin®" (1 trials), "Herceptin" (1 trials) and "INCAGN02385" (1 trials). Other intervention names were less common.

The vast majority of trials in "LTD Cancer Research Centre" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "LTD Cancer Research Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LTD Cancer Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LTD Cancer Research Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".